NJ Life Sciences Report Highlights Sector Growth and Global Competitiveness
Choose New Jersey, the state’s leading nonprofit business attraction organization, has released the 2026 New Jersey Life Sciences Report, an analysis of New Jersey’s thriving life sciences ecosystem. Developed in partnership with BioNJ, the HealthCare Institute of New Jersey (HINJ), Jones Lang LaSalle Incorporated (JLL), and the New Jersey Economic Development Authority (NJEDA), the report highlights key industry trends, real estate and development opportunities, workforce strengths, and state-supported programs driving growth across the sector.
The report highlights New Jersey’s commitment to innovation, including more than $190 million in recent state investments in incubators and accelerator programs. These investments are helping early-stage companies grow while strengthening the broader life sciences ecosystem that supports companies across all stages of development and commercialization.
“New Jersey offers one of the most advantageous environments in the world for life sciences companies,” said Gov. Mikie Sherrill. “The organizations that created the state’s third-annual Life Sciences Report are ready to support the next wave of New Jersey healthcare and biotech innovators. Our state already has much to offer life sciences companies looking to grow and invest in a region with unmatched potential, and my administration is committed to making New Jersey even more business-friendly.
The report highlights New Jersey’s continued growth in life sciences manufacturing capacity, including 1.5 million square feet of new CDMO and biomanufacturing space added since 2021. It also underscores the state’s leadership in cell and gene therapy, noting that New Jersey is home to six of the 13 FDA-approved cell and gene therapies in the United States. This strength is supported by ongoing investment in the state’s biomanufacturing workforce through programs such as NJBioFutures, which partners with industry and academic institutions to prepare job-ready talent for roles across the life sciences sector.